Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.600
-0.100 (-2.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Turn Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cost of Revenue | 0.5 | - | - | - |
| Gross Profit | -0.5 | - | - | - |
| Selling, General & Admin | 5.59 | 1.55 | 2.3 | 4.21 |
| Research & Development | 0.27 | 0.25 | 0.01 | - |
| Operating Expenses | 5.86 | 1.8 | 2.31 | 4.21 |
| Operating Income | -6.36 | -1.8 | -2.31 | -4.21 |
| Interest Expense | - | - | - | -0.09 |
| Interest & Investment Income | 0.03 | 0.03 | 0.02 | 0.01 |
| Other Non Operating Income (Expenses) | 3.13 | - | - | - |
| Pretax Income | -3.19 | -1.77 | -2.29 | -4.29 |
| Income Tax Expense | - | - | - | 0 |
| Net Income | -3.19 | -1.77 | -2.29 | -4.29 |
| Net Income to Common | -3.19 | -1.77 | -2.29 | -4.29 |
| Shares Outstanding (Basic) | 28 | 27 | 26 | - |
| Shares Outstanding (Diluted) | 28 | 27 | 26 | - |
| Shares Change (YoY) | 4.03% | 0.56% | - | - |
| EPS (Basic) | -0.12 | -0.07 | -0.09 | - |
| EPS (Diluted) | -0.12 | -0.07 | -0.09 | - |
| EBITDA | -6.3 | -1.75 | -2.26 | -4.16 |
| D&A For EBITDA | 0.05 | 0.05 | 0.04 | 0.05 |
| EBIT | -6.36 | -1.8 | -2.31 | -4.21 |
Source: S&P Capital IQ. Standard template.
Financial Sources.